PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 19, 2022JAMA Neurology232 citationsOpen Access

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

SOSusanne OstrowitzkiTBTobias BittnerKSKaycee M. Sink

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifiers: CREAD, NCT02670083; CREAD2, NCT03114657.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ostrowitzki et al. (2022) studied this question.

synapsesocial.com/papers/69dab5660f32475823a3d9dahttps://doi.org/10.1001/jamaneurol.2022.2909
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin2016 · 122 citations
  2. 2The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults2011 · 5,192 citations
  3. 3The Hidden Victims of Alzheimer's Disease: Families Under Stress1985 · 797 citations
  4. 4“Mini-mental state”1975 · 87,447 citations
  5. 5A new rating scale for Alzheimer's disease1984 · 4,230 citations